Correlation Between Achilles Therapeutics and Day One

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Achilles Therapeutics and Day One at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Achilles Therapeutics and Day One into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Achilles Therapeutics PLC and Day One Biopharmaceuticals, you can compare the effects of market volatilities on Achilles Therapeutics and Day One and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Achilles Therapeutics with a short position of Day One. Check out your portfolio center. Please also check ongoing floating volatility patterns of Achilles Therapeutics and Day One.

Diversification Opportunities for Achilles Therapeutics and Day One

-0.48
  Correlation Coefficient

Very good diversification

The 3 months correlation between Achilles and Day is -0.48. Overlapping area represents the amount of risk that can be diversified away by holding Achilles Therapeutics PLC and Day One Biopharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Day One Biopharmaceu and Achilles Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Achilles Therapeutics PLC are associated (or correlated) with Day One. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Day One Biopharmaceu has no effect on the direction of Achilles Therapeutics i.e., Achilles Therapeutics and Day One go up and down completely randomly.

Pair Corralation between Achilles Therapeutics and Day One

Given the investment horizon of 90 days Achilles Therapeutics PLC is expected to generate 1.67 times more return on investment than Day One. However, Achilles Therapeutics is 1.67 times more volatile than Day One Biopharmaceuticals. It trades about 0.17 of its potential returns per unit of risk. Day One Biopharmaceuticals is currently generating about 0.03 per unit of risk. If you would invest  119.00  in Achilles Therapeutics PLC on November 8, 2024 and sell it today you would earn a total of  20.00  from holding Achilles Therapeutics PLC or generate 16.81% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Achilles Therapeutics PLC  vs.  Day One Biopharmaceuticals

 Performance 
       Timeline  
Achilles Therapeutics PLC 

Risk-Adjusted Performance

Good

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Achilles Therapeutics PLC are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite quite weak technical indicators, Achilles Therapeutics disclosed solid returns over the last few months and may actually be approaching a breakup point.
Day One Biopharmaceu 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Day One Biopharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain very healthy which may send shares a bit higher in March 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Achilles Therapeutics and Day One Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Achilles Therapeutics and Day One

The main advantage of trading using opposite Achilles Therapeutics and Day One positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Achilles Therapeutics position performs unexpectedly, Day One can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Day One will offset losses from the drop in Day One's long position.
The idea behind Achilles Therapeutics PLC and Day One Biopharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum